{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:48:04Z","timestamp":1782110884407,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,21]],"date-time":"2027-04-21T00:00:00Z","timestamp":1808265600000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["ZIA BC011513"],"award-info":[{"award-number":["ZIA BC011513"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canlet.2026.218515","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:29:44Z","timestamp":1776284984000},"page":"218515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Understanding tumor microenvironment dynamics and immune checkpoint inhibitor efficacy following mEGFR-targeted near-infrared photoimmunotherapy"],"prefix":"10.1016","volume":"650","author":[{"given":"Seiichiro","family":"Takao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-4219","authenticated-orcid":false,"given":"Aki","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyu","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motofumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7548-1580","authenticated-orcid":false,"given":"Hiroshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1019-4112","authenticated-orcid":false,"given":"Hisataka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218515_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/intimm\/dxaa037","article-title":"Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity","volume":"33","author":"Kobayashi","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.canlet.2026.218515_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell\u2013selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218515_bib3","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acs.accounts.9b00273","article-title":"Near-infrared photoimmunotherapy of cancer","volume":"52","author":"Kobayashi","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.canlet.2026.218515_bib4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1021\/acsptsci.1c00184","article-title":"Electron donors rather than reactive oxygen species needed for therapeutic photochemical reaction of near-infrared photoimmunotherapy","volume":"4","author":"Kato","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.canlet.2026.218515_bib5","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.18632\/oncotarget.14425","article-title":"Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity","volume":"8","author":"Ogawa","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218515_bib6","first-page":"15","article-title":"Review of RM-1929 near-infrared photoimmunotherapy clinical efficacy for unresectable and\/or recurrent head and neck squamous cell carcinoma","author":"Miyazaki","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218515_bib7","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.21873\/anticanres.17218","article-title":"Feasibility of near-infrared photoimmunotherapy combined with immune checkpoint inhibitor therapy in unresectable head and neck cancer","volume":"44","author":"Hirakawa","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2026.218515_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hed.70014","article-title":"Safety and efficacy findings from a phase Ib\/II study of ASP-1929 photoimmunotherapy with pembrolizumab in recurrent and\/or metastatic head and neck squamous cell carcinoma","volume":"48","author":"Cognetti","year":"2026","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2026.218515_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218515_bib10","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1158\/1541-7786.MCR-17-0333","article-title":"Syngeneic mouse models of oral cancer are effectively targeted by Anti-CD44-Based NIR-PIT","volume":"15","author":"Nagaya","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218515_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/2326-6066.CIR-19-0517","article-title":"Combined CD44- and CD25-Targeted near-infrared photoimmunotherapy selectively kills cancer and regulatory T cells in syngeneic mouse cancer models","volume":"8","author":"Maruoka","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218515_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.2019922","article-title":"CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model","volume":"11","author":"Furusawa","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2026.218515_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105566","article-title":"Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugates","volume":"112","author":"Adachi","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2026.218515_bib14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s10120-025-01623-9","article-title":"A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901)","volume":"28","author":"Kadota","year":"2025","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.canlet.2026.218515_bib15","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1111\/cas.15965","article-title":"Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700","volume":"114","author":"Takao","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218515_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114390","article-title":"Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases","volume":"160","author":"Inagaki","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218515_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136829","article-title":"Near infrared photoimmunotherapy targeting EGFR positive triple negative breast cancer: optimizing the conjugate-light regimen","volume":"10","author":"Nagaya","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218515_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102132","article-title":"Near-infrared photoimmunotherapy for osteosarcoma targeting epidermal growth factor receptor","volume":"50","author":"Suzuki","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218515_bib19","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1172\/JCI80012","article-title":"Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade","volume":"125","author":"Buchbinder","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218515_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218515_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061440","article-title":"CTLA-4 in regulatory T cells for cancer immunotherapy","volume":"13","author":"Sobhani","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218515_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.21037\/atm-23-754","article-title":"CheckMate-915: does adjuvant CTLA-4 blockade play a role in resected melanoma?","volume":"11","author":"Su","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218515_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1200\/JCO.22.01770","article-title":"Induction exposure dose of ipilimumab and failure of adjuvant nivolumab plus ipilimumab in Melanoma","volume":"41","author":"Augustin","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218515_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2019.12.010","article-title":"Resistance to checkpoint inhibition in cancer immunotherapy","volume":"13","author":"Barrueto","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218515_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1470-2045(17)30231-0","article-title":"Ipilimumab 10 mg\/kg versus ipilimumab 3 mg\/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial","volume":"18","author":"Ascierto","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218515_bib26","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/annonc\/mdu441","article-title":"Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies","volume":"25","author":"Lebb\u00e9","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218515_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1158\/1535-7163.MCT-22-0313","article-title":"Near-infrared photoimmunotherapy targeting podoplanin-expressing cancer cells and cancer-associated fibroblasts","volume":"22","author":"Kato","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218515_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217906","article-title":"Preserved host immunity with intercellular adhesion molecule-1 (ICAM-1)-targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of triple-negative breast cancer and other malignancies","volume":"630","author":"Takao","year":"2025","journal-title":"Cancer Lett."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:14:21Z","timestamp":1782108861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"alternative-id":["S0304383526002788"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218515","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding tumor microenvironment dynamics and immune checkpoint inhibitor efficacy following mEGFR-targeted near-infrared photoimmunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218515"}}